Skip to main navigation Skip to search Skip to main content

International guidelines on the diagnosis and treatment of NUT carcinoma

  • Yu Zhang
  • , Qi Zhang
  • , Yue Hao
  • , Jia Luo
  • , Yingshi Piao
  • , Wenxian Wang
  • , Zhengbo Song
  • , Ziming Li
  • , Luka Brcic
  • , Aijun Liu
  • , Jinpu Yu
  • , Yasuhiro Tsutani
  • , Wenzhao Zhong
  • , Wenfeng Fang
  • , Zhijie Wang
  • , Shengxiang Ren
  • , Athanasios G. Papavassiliou
  • , Yongchang Zhang
  • , Jingjing Liu
  • , Shirong Zhang
  • Xiuyu Cai, Ayten Kayi Cangir, Anwen Liu, Wen Li, Filippo Lococo, Ping Zhan, Hongbing Liu, Tangfeng Lv, Liyun Miao, Lingfeng Min, Helmut Popper, Yu Chen, Jingping Yuan, Feng Wang, Zhansheng Jiang, Gen Lin, Long Huang, Xingxiang Pu, Rongbo Lin, Kalevi Kairemo, Weifeng Liu, Chuangzhou Rao, Dongqing Lv, Zongyang Yu, Ashrafian Leanne, Xiaoyan Li, Chuanhao Tang, Hifzur R. Siddique, Chengzhi Zhou, Junping Zhang, Junli Xue, Vishal Shelat, Hui Guo, Qian Chu, Rui Meng, Fatemeh Ardeshir, Jingxun Wu, Rui Zhang, Jin Zhou, Robert A. Kratzke, Zhengfei Zhu, Yongheng Li, Hong Qiu, Fan Xia, Fiorella Calabrese, Yang Xia, Alessandro Wasum Mariani, Yuanyuan Lu, Xiaofeng Chen, Mark A. Klein, Rui Ge, Enyong Dai, Axel H. Schönthal, Yu Han, Zhenying Guo, Jian Zhang, Yinghua Ji, Xianbin Liang, Hongmei Zhang, Xuelei Ma, Marco Chiappetta, Xuewen Liu, Francoise Galateau Salle, Yu Yao, Malgorzata Szolkowska, Weiwei Pan, Fei Pang, Fan Wu, Stefan B. Watzka, Liping Wang, Youcai Zhu, Li Lin, Aparna Sharma, Jianfei Tu, Xinqing Lin, Jing Cai, Ling Xu, Jisheng Li, Xiaodong Jiao, Kainan Li, Marjorie G. Zauderer, Jia Wei, Huijing Feng, Lin Wang, Yingying Du, Wang Yao, Elizabeth Dudnik, Xuefei Shi, Xiaomin Niu, Dongmei Yuan, Yanwen Yao, Jianhui Huang, Yue Feng, Yinbin Zhang, Binbin Song, Wenfeng Li, Jianfei Fu, Marina K. Baine, Pingli Sun, Hong Wang, Mingxiang Ye, Dong Wang, Zhaofeng Wang, Jing Wu, Yunyun Yang, Yuan Fang, Zhen Wang, Bin Wan, Donglai Lv, Huafei Chen, Shengjie Yang, Jing Kang, Jiatao Zhang, Chao Zhang, Lin Shi, Yina Wang, Mohamed Emam Sobeih, Bihui Li, Bin Lian, Lili Mao, Zhang Zhang, Ke Wang, Zhongwu Li, Zhefeng Liu, Nong Yang, Lin Wu, Xiaobing Chen, Gu Jin, Miao Li, Guansong Wang, Thomas U. Marron, Jiandong Wang, Sanjay Popat, Meiyu Fang, Yong Fang, Daniel Mansilla, Yuan Li, Xiaojia Wang, Jing Chen, Yiping Zhang, Xixu Zhu, Yi Shen, Shenglin Ma, Aaron S. Mansfield, Biyun Wang, Lu Si, Anja C. Roden, Bjørn H. Grønberg, Yong Song, Geoffrey I. Shapiro, Christopher A. French, Yuanzhi Lu, Qian Wang, Chunwei Xu

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

Public summary•BRD4:NUTM1 is the fusion oncogene driver in ∼70% of NUT carcinomas.•NUT IHC is recommended as an initial screening for malignant tumors exhibiting poorly differentiated phenotype.•Existing chemotherapy regimens and BET inhibitors have limited efficacy in NUT carcinoma.•For patients with advanced NUT carcinoma, rational clinical trial combinations should be considered.

Original languageEnglish
Article number101068
JournalInnovation
Volume7
Issue number1
DOIs
StatePublished - 5 Jan 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Clinical Medicine
  • NUT carcinoma
  • diagnosis
  • guideline
  • treatment

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'International guidelines on the diagnosis and treatment of NUT carcinoma'. Together they form a unique fingerprint.

Cite this